Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stadler

Showing results (441-450 of 724) with videos related to

Pageof 73
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Allergen mimotopes in food enhance type I allergic reactions in miceE Jensen-Jarolim, U Wiedermann, E Ganglberger, et al.
Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.
Cancer|January 16, 2007
A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationSupriya G Mohile, Kathryn Bylow, William Dale, et al.
Pediatric Radiology|June 13, 2023
Evaluation of the diagnostic performance of physician lung ultrasound versus chest radiography for pneumonia diagnosis in a peri-urban South African cohortShyam Sunder B Venkatakrishna, Jacob A M Stadler, Tracy Kilborn, et al.
International Archives of Allergy and Immunology|January 21, 2000
Interaction of human IgE with Fc epsilon RI alpha exposes hidden epitopes on IgEA Nechansky, C Ruf, E Pursch, et al.
Vox Sanguinis|October 26, 1999
Degradation products of factor VIII which can lead to increased immunogenicityD Josić, A Buchacher, C Kannicht, et al.
Urologic Oncology|December 12, 2002
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancerWalter M Stadler, Annamaria Hayden, Hans von der Maase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901Walter M Stadler, Gary Rosner, Eric Small, et al.
Investigational New Drugs|April 27, 2007
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)Charles J Ryan, Walter M Stadler, Bruce Roth, et al.
Pageof 73

Showing results (441-450 of 724) with videos related to

Sort By:
Pageof 73
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Allergen mimotopes in food enhance type I allergic reactions in miceE Jensen-Jarolim, U Wiedermann, E Ganglberger, et al.
Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.
Cancer|January 16, 2007
A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationSupriya G Mohile, Kathryn Bylow, William Dale, et al.
Pediatric Radiology|June 13, 2023
Evaluation of the diagnostic performance of physician lung ultrasound versus chest radiography for pneumonia diagnosis in a peri-urban South African cohortShyam Sunder B Venkatakrishna, Jacob A M Stadler, Tracy Kilborn, et al.
International Archives of Allergy and Immunology|January 21, 2000
Interaction of human IgE with Fc epsilon RI alpha exposes hidden epitopes on IgEA Nechansky, C Ruf, E Pursch, et al.
Vox Sanguinis|October 26, 1999
Degradation products of factor VIII which can lead to increased immunogenicityD Josić, A Buchacher, C Kannicht, et al.
Urologic Oncology|December 12, 2002
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancerWalter M Stadler, Annamaria Hayden, Hans von der Maase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901Walter M Stadler, Gary Rosner, Eric Small, et al.
Investigational New Drugs|April 27, 2007
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)Charles J Ryan, Walter M Stadler, Bruce Roth, et al.
Pageof 73